Toward a Reliable Distinction Between Patients with Mild Cognitive Impairment and Alzheimer-Type Dementia Versus Major Depression
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 • 13,092 citations
Current Concepts in Mild Cognitive Impairment
2001 • 4,609 citations
CSF markers for incipient Alzheimer's disease
2003 • 1,257 citations
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
1997 • 991 citations
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery
1994 • 917 citations
Detection of Abnormal Memory Decline in Mild Cases of Alzheimer's Disease Using CERAD Neuropsychological Measures
1991 • 720 citations
Depression in Patients With Mild Cognitive Impairment Increases the Risk of Developing Dementia of Alzheimer Type
2004 • 506 citations
Early Detection and Differential Diagnosis of Alzheimer’s Disease and Depression with Neuropsychological Tasks
2001 • 370 citations
Patterns of Cognitive Decline in Presymptomatic Alzheimer Disease
2001 • 366 citations
Detecting Dementia: Novel Neuropsychological Markers of Preclinical Alzheimer’s Disease
2003 • 331 citations
Value of CSF β-amyloid1–42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment
2003 • 297 citations
α-Secretase ADAM10 as Well as αAPPs Is Reduced in Platelets and CSF of Alzheimer Disease Patients
2002 • 229 citations
Levels of α- and β-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients
2000 • 185 citations
Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's diseas
1995 • 173 citations
Biochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluid
2002 • 168 citations
Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment
2003 • 162 citations
Cerebrospinal fluid markers for prediction of Alzheimer's disease
2003 • 161 citations
Diagnostic Utility of Letter Fluency, Category Fluency, and Fluency Difference Scores in Alzheimer's Disease
2002 • 129 citations
Qualitative analysis of verbal fluency in depression
2003 • 127 citations
Measurement of α- and β-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
2003 • 127 citations
Repetitive transcranial magnetic stimulation in rats: evidence for a neuroprotective effect in vitro and in vivo
1999 • 120 citations
Platelet APP isoform ratios correlate with declining cognition in AD
2000 • 106 citations
Neuropathologic Correlates of Late-Onset Major Depression
2004 • 102 citations
Abnormalities in the Pattern of Platelet Amyloid Precursor Protein Forms in Patients With Mild Cognitive Impairment and Alzheimer Disease
2002 • 97 citations
Cerebrospinal Fluid Levels of Amyloid Precursor Protein and Amyloid β-Peptide in Alzheimer’s Disease and Major Depression – Inverse Correlation with Dementia Severity
1998 • 82 citations
Cerebrospinal Fluid Levels of -Secretase--Cleaved Soluble Amyloid Precursor Protein Mirror Cognition in a Swedish Family With Alzheimer Disease and a Gene Mutation
1997 • 77 citations
Platelet Amyloid Precursor Protein Abnormalities in Mild Cognitive Impairment Predict Conversion to Dementia of Alzheimer Type
2003 • 60 citations
The β-Amyloid Precursor Protein and its Derivatives: From Biology to Learning and Memory Processes
2000 • 52 citations
BRIEF COMMUNICATION
1997 • 27 citations
Distinguishing between Patients with Depression or Very Mild Alzheimer's Disease Using the Delayed-Word-Recall Test
1997 • 23 citations